SAM
COGT icon

Smartleaf Asset Management’s Cogent Biosciences COGT Stock Holding History

Smartleaf Asset Management’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.4K Hold
424
– – ﹤0.01% 2118
2026
Q1 		$15K Buy
424
+134
+46% +$4.95K ﹤0.01% 2114
2025
Q4 		$10.8K Buy
290
+246
+559% +$6.92K ﹤0.01% 2367
2025
Q3 		$621 Buy
+44
New +$521 ﹤0.01% 2822
2025
Q1 		– Sell
-273
Closed -$2.1K – 2892
2024
Q4 		$2.1K Hold
273
– – ﹤0.01% 2523
2024
Q3 		$2.98K Hold
273
– – ﹤0.01% 2340
2024
Q2 		$2.3K Buy
+273
New +$2.07K ﹤0.01% 2175

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Smartleaf Asset Management's COGT Position: Q2 2026 in Review

Smartleaf Asset Management held its Cogent Biosciences (COGT) position steady in Q2 2026 at 424 shares worth $16.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2118.

Smartleaf Asset Management first reported a position in COGT in Q2 2024 and has held it in 7 quarters since. 323 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Smartleaf Asset Management held 424 shares of Cogent Biosciences worth $16.4K as of Q2 2026.
  • Smartleaf Asset Management left its Cogent Biosciences share count unchanged in Q2 2026.
  • Cogent Biosciences made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2118 holding.
  • Smartleaf Asset Management first reported a position in Cogent Biosciences in Q2 2024 and has held it in 7 quarters since.
  • 323 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.